AstraZeneca PLC
NASDAQ:AZN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
61.03
87.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
AstraZeneca PLC
Wall Street
Price Targets
AZN Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for
AZN
is 86.66 USD
with a low forecast of 40.98 USD and a high forecast of 120.43 USD.
AZN Last Price Targets
AstraZeneca PLC
The latest public price target was made on Nov 13, 2024 by
Etzer Darout
from
BMO Capital
,
who expects
AZN
stock to
rise by 35%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Etzer Darout
BMO Capital
|
88
USD
Upside 35% |
1 month ago
Nov 13, 2024
|
AstraZeneca (AZN) PT Lowered to $88 at BMO Capital
StreetInsider
|
|
Etzer Darout
BMO Capital
|
89
USD
Upside 36% |
3 months ago
Sep 11, 2024
|
BMO Capital Reiterates Outperform Rating on AstraZeneca (AZN)
StreetInsider
|
John Eade
Argus Research
|
85
USD
Upside 30% |
6 months ago
May 30, 2024
|
AstraZeneca (AZN) PT Raised to $85 at Argus
StreetInsider
|
|
Etzer Darout
BMO Capital
|
82
USD
Upside 25% |
6 months ago
May 28, 2024
|
BMO Capital Reiterates Outperform Rating on AstraZeneca (AZN)
StreetInsider
|
|
Andrew Berens
Leerink Partners
|
79
USD
Upside 21% |
1 year ago
Jul 12, 2023
|
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AZN's stock price target?
Price Target
86.66
USD
According to Wall Street analysts, the average 1-year price target for
AZN
is 86.66 USD
with a low forecast of 40.98 USD and a high forecast of 120.43 USD.
What is AstraZeneca PLC's Revenue forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
AstraZeneca PLC's revenue is
8%.
The projected
CAGR
for the next 4 years is
9%.
What is AstraZeneca PLC's Operating Income forecast?
Projected CAGR
27%
For the last 8 years the
compound annual growth rate for
AstraZeneca PLC's operating income is
6%.
The projected
CAGR
for the next 4 years is
27%.
What is AstraZeneca PLC's Net Income forecast?
Projected CAGR
32%
For the last 8 years the
compound annual growth rate for
AstraZeneca PLC's net income is
10%.
The projected
CAGR
for the next 4 years is
32%.
You don't have any saved screeners yet
